E
Sell
12/26/2023Upgraded
BioNeutra Global Corporation (BGACF) was upgraded to E+ from E- on 12/26/2023 due to an increase in the volatility index.
E
Sell
12/1/2023Downgrade
BioNeutra Global Corporation (BGACF) was downgraded to E- from E+ on 12/1/2023 due to a decline in the total return index, volatility index and solvency index. Debt to equity increased from -1.07 to -0.95, and the quick ratio declined from 0.11 to 0.11.
E
Sell
11/23/2022Downgrade
BioNeutra Global Corporation (BGACF) was downgraded to E+ from D- on 11/23/2022 due to a significant decline in the growth index and solvency index. Earnings per share declined from $0.002 to -$0.023, EBIT declined 260.51% from $225.9 to -$362.6, and the quick ratio declined from 0.24 to 0.13.
D
Sell
9/1/2022Upgraded
BioNeutra Global Corporation (BGACF) was upgraded to D- from E on 09/01/2022.
E
Sell
6/1/2022Upgraded
BioNeutra Global Corporation (BGACF) was upgraded to E from E- on 6/1/2022 due to a substantial increase in the growth index, total return index and solvency index. Operating cash flow increased 149.85% from $463 to $1.16M, earnings per share increased from -$0.0111 to $0.002, and EBIT increased 116.97% from -$1.33M to $225.9.
E
Sell
2/28/2022None
BioNeutra Global Corporation (BGACF) was downgraded to E- from U on 02/28/2022.
